Chaparral Labs
back to search

protein

Alkyldihydroxyacetonephosphate synthase, peroxisomal

aka Alkyl-DHAP synthase

AGPS
protein:O00116disease:adad:direction:down

Gene

AGPS

Organism

Homo sapiens(9606)

Length

658 aa

Mass

72,912 Da

AI summarysource-grounded · cited inline
claude-haiku-4-5-20251001

Alkyldihydroxyacetonephosphate synthase (AGPS) is a peroxisomal enzyme that catalyzes the exchange of acyl chains in acyl-DHAP for long-chain fatty alcohols, producing alkyl-DHAP as the first ether-linked intermediate in ether lipid biosynthesis (UniProt: O00116). The enzyme is expressed in human tissues involved in lipid metabolism and cellular signaling. Mutations in AGPS cause rhizomelic chondrodysplasia punctata type 3 (RCDP3), a severe genetic disorder marked by skeletal dysplasia, dwarfism, cataracts, and intellectual disability.

AGPS is associated with Alzheimer's Disease and shows significant downregulation in post-mortem AD brain tissue compared to age-matched controls (Chaparral AD proteomics: mean log2 fold-change −0.62). This reduction was detected across subcellular fractions in TMT-labeled quantitative proteomics analysis of human AD brain samples. The downregulation of ether lipid biosynthesis machinery in AD suggests potential disruption of myelin composition and neuronal membrane integrity, which may contribute to neurodegeneration in Alzheimer's disease pathology.

Generated from the curated entity record below. May contain errors — verify against source links.

Proteomics Evidence · AD

↓ Down in AD

P3

not detected

P2

not detected

S2

not detected

S3

-0.619

Mean log₂FC across detected fractions: -0.6193 (1 of 4 fractions detected)

Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.

Related Publications

Browse all →

Function

Catalyzes the exchange of the acyl chain in acyl-dihydroxyacetonephosphate (acyl-DHAP) for a long chain fatty alcohol, yielding the first ether linked intermediate, i.e. alkyl-dihydroxyacetonephosphate (alkyl-DHAP), in the pathway of ether lipid biosynthesis

Disease associations

  • Rhizomelic chondrodysplasia punctata 3RCDP3

    A form of rhizomelic chondrodysplasia punctata, a disease characterized by severely disturbed endochondral bone formation, rhizomelic shortening of femur and humerus, vertebral disorders, dwarfism, cataract, cutaneous lesions, facial dysmorphism, and severe intellectual disability with spasticity.

Sources

Last updated 5/8/2026, 6:36:00 AM